Concerning the liver, it counteracted steatosis and inhibited the NF-κB pathway, of which is associated with nonalcoholic fatty liver disease (NAFLD) [205]. The gene discussed is NFKB1; the disease is metabolic dysfunction-associated steatotic liver disease.